Zobrazeno 1 - 10
of 137
pro vyhledávání: '"Andrea, Veronesi"'
Autor:
Samuele Massarut, Gustavo Baldassarre, Alfonso Colombatti, Kurt S. Zaenker, Mauro G. Trovò, Vincenzo Canzonieri, Andrea Veronesi, Sonia Reccanello, Ezio Candiani, Tiziana Perin, Stefania Berton, Francesca Lovat, Mario Roncadin, Frank Entschladen, Sara D'Andrea, Jayant S. Vaidya, Barbara Belletti
Purpose: After apparently successful excision of breast cancer, risk of local recurrence remains high mainly in the area surrounding the original tumor, indicating that wound healing processes may be implicated. The proportional reduction of this ris
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::25fa2bd76b7ad7538048a5acf2d5f5e5
https://doi.org/10.1158/1078-0432.c.6518337.v1
https://doi.org/10.1158/1078-0432.c.6518337.v1
Autor:
Samuele Massarut, Gustavo Baldassarre, Alfonso Colombatti, Kurt S. Zaenker, Mauro G. Trovò, Vincenzo Canzonieri, Andrea Veronesi, Sonia Reccanello, Ezio Candiani, Tiziana Perin, Stefania Berton, Francesca Lovat, Mario Roncadin, Frank Entschladen, Sara D'Andrea, Jayant S. Vaidya, Barbara Belletti
Supplementary Data from Targeted Intraoperative Radiotherapy Impairs the Stimulation of Breast Cancer Cell Proliferation and Invasion Caused by Surgical Wounding
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bd8043e0ce491fc2bb923943fbec1fa5
https://doi.org/10.1158/1078-0432.22441209.v1
https://doi.org/10.1158/1078-0432.22441209.v1
Publikováno v:
Personalized Management of Breast Cancer. :120-131
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f78838a0e5eeaa2ba65c36d9d904921b
https://doi.org/10.2217/ebo.13.409
https://doi.org/10.2217/ebo.13.409
Autor:
Gianni Del Sal, Olimpia Siclari, Natalie Turner, Alberto Zambelli, Angelo Di Leo, Ilenia Migliaccio, Libero Santarpia, Andrea Veronesi, Erica Moretti, Stefano Piccolo, Maurizio D'Incalci
Publikováno v:
Cancer Treatment Reviews. 39:541-550
Triple negative breast cancers, which are defined by lack of expression of estrogen, progesterone, or HER2 receptors, represent approximately 15% of all breast cancers, although they account for a much higher proportional of breast cancer mortality.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::93627090590a69dd2aed85ba8a78bf4d
https://doi.org/10.1016/j.ctrv.2012.12.001
https://doi.org/10.1016/j.ctrv.2012.12.001
Autor:
Manuela La Grassa, Alessandro Tuzi, Samuele Massarut, Loredana Militello, Diana Crivellari, Tiziana Perin, Davide Lombardi, Andrea Veronesi
Publikováno v:
Radiology and Oncology
Background. We report on the activity of the combination of epirubicin and docetaxel given in neoadjuvant setting for 4 and 8 cycles respectively in 2 successive series of patients with large operable or locally advanced, hormone receptor positive, H
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4f9720d370f0ae7400be61f56f4f0b02
https://doi.org/10.2478/raon-2013-0012
https://doi.org/10.2478/raon-2013-0012
Autor:
Diana, Crivellari, Simon, Spazzapan, Davide, Lombardi, Loredana, Militello, Elena, Torrisi, Alessia E, Russo, Roberto, Sorio, Renato, Talamini, Gianmaria, Miolo, Paolo, Carli, Andrea, Veronesi
Publikováno v:
Tumori Journal. 98:33-38
Aims and Background Lapatinib in combination with capecitabine is feasible in patients with HER2-positive metastatic breast cancer pretreated with anthracyclines, taxanes and trastuzumab, but inferior results were reported in the global lapatinib exp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1016a59ccbcd360417acaf4eaec4ace2
https://doi.org/10.1177/030089161209800104
https://doi.org/10.1177/030089161209800104
Autor:
Roberto Sorio, Davide Adriano Santeufemia, Simona Scalone, Gianmaria Miolo, Andrea Veronesi, Giampiero Capobianco, Ettore Bidoli, Simon Spazzapan, Francesco Dessole, Gianna Tabaro, Davide Lombardi
Publikováno v:
Archives of Gynecology and Obstetrics. 285:499-503
To evaluate the disease control rate (DCR) in heavily pretreated and relapsed ovarian cancer patients re-challenged with a weekly paclitaxel schedule and to establish whether a correlation between dose intensity, progression-free interval (PFI) and o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bc312d55b4dd0825b9c351adaf6982af
https://doi.org/10.1007/s00404-011-1976-9
https://doi.org/10.1007/s00404-011-1976-9
Autor:
Simon Spazzapan, Gianmaria Miolo, Simona Scalone, Philippe L. Bedard, Andrea Veronesi, Davide Lombardi, Diana Crivellari
Publikováno v:
Expert Opinion on Pharmacotherapy. 12:945-960
Over the last few decades, the population of developed countries has aged. Breast cancer is the most common cancer among the increased numbers of older women. The choice of adjuvant treatment is particularly difficult in older women because the oncol
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::35f9fae96649297a6353be3b180826c6
https://doi.org/10.1517/14656566.2011.540570
https://doi.org/10.1517/14656566.2011.540570
Autor:
Andrea Veronesi, Samuele Massarut, Tiziana Perin, Gian Maria Miolo, Simona Scalone, Diana Crivellari, Francesco Coran, M. D. Magri, Antonio Murrone, E Candiani, Davide Lombardi, Nicoletta La Mura
Publikováno v:
Scopus-Elsevier
Aims and background Neoadjuvant chemotherapy is the standard treatment for locally advanced breast cancer. The combination of anthracyclines and taxanes is considered the first choice chemotherapy in advanced breast cancer. We report here the overall
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4b000fd502da98d9892756e119e47b0e
https://doi.org/10.1177/030089161009600207
https://doi.org/10.1177/030089161009600207
Autor:
D. Fantin, Agostino Steffan, M. De Cicco, Fabio Fabiani, Mira Matovic, C. A. Bertuzzi, Luca Balestreri, Ettore Bidoli, Sandro Morassut, R. Pacenzia, Andrea Veronesi, M. Malafronte
Publikováno v:
Annals of Oncology. 20:1936-1942
Background: We evaluated efficacy and safety of early and short-term prophylaxis with acenocumarine or dalteparin in the prevention of non-occlusive or occlusive central vein catheter-related thrombosis (CVCrT). Patients and methods: Consecutive canc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::deb4cf2ed0d1fbb2a634dc635e8531fc
https://doi.org/10.1093/annonc/mdp235
https://doi.org/10.1093/annonc/mdp235